Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Journal of Clinical Microbiology|November 18, 2011
Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamideSami O Simons, Jakko van Ingen, Tridia van der Laan, et al.
Journal of Gastroenterology and Hepatology|November 13, 2007
Antituberculosis drug-induced hepatotoxicity: concise up-to-date reviewAlma Tostmann, Martin J Boeree, Rob E Aarnoutse, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2025
Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TBCaryn M Upton, Jose M Calderin, Andreas H Diacon, et al.
Journal of Clinical Microbiology|April 19, 2013
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activityXavier A Kayigire, Sven O Friedrich, Amour Venter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Clinical relevance of Mycobacterium szulgai in The NetherlandsJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
International Journal of Antimicrobial Agents|May 9, 2015
SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis modelGerjo J de Knegt, Irma A J M Bakker-Woudenberg, Dick van Soolingen, et al.
ERJ Open Research|October 30, 2020
Subtle immunodeficiencies in nodular-bronchiectatic <i>Mycobacterium avium</i> complex lung diseaseMariolina Bruno, Sanne M H Zweijpfenning, Jeske Verhoeven, et al.
Emerging Infectious Diseases|March 8, 2008
Mycobacterium xenopi clinical relevance and determinants, the NetherlandsJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Antimicrobial Resistance and Infection Control|January 4, 2019
Nosocomial outbreak of multi-resistant <i>Streptococcus pneumoniae</i> serotype 15A in a centre for chronic pulmonary diseasesGuido J H Bastiaens, Amelieke J H Cremers, Jordy P M Coolen, et al.
International Journal of Antimicrobial Agents|July 11, 2009
Hydrazine-induced liver toxicity is enhanced by glutathione depletion but is not mediated by oxidative stress in HepG2 cellsEvelyn Olthof, Alma Tostmann, Wilbert H M Peters, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|November 18, 2011
Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamideSami O Simons, Jakko van Ingen, Tridia van der Laan, et al.
Journal of Gastroenterology and Hepatology|November 13, 2007
Antituberculosis drug-induced hepatotoxicity: concise up-to-date reviewAlma Tostmann, Martin J Boeree, Rob E Aarnoutse, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2025
Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TBCaryn M Upton, Jose M Calderin, Andreas H Diacon, et al.
Journal of Clinical Microbiology|April 19, 2013
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activityXavier A Kayigire, Sven O Friedrich, Amour Venter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Clinical relevance of Mycobacterium szulgai in The NetherlandsJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
International Journal of Antimicrobial Agents|May 9, 2015
SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis modelGerjo J de Knegt, Irma A J M Bakker-Woudenberg, Dick van Soolingen, et al.
ERJ Open Research|October 30, 2020
Subtle immunodeficiencies in nodular-bronchiectatic <i>Mycobacterium avium</i> complex lung diseaseMariolina Bruno, Sanne M H Zweijpfenning, Jeske Verhoeven, et al.
Emerging Infectious Diseases|March 8, 2008
Mycobacterium xenopi clinical relevance and determinants, the NetherlandsJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Antimicrobial Resistance and Infection Control|January 4, 2019
Nosocomial outbreak of multi-resistant <i>Streptococcus pneumoniae</i> serotype 15A in a centre for chronic pulmonary diseasesGuido J H Bastiaens, Amelieke J H Cremers, Jordy P M Coolen, et al.
International Journal of Antimicrobial Agents|July 11, 2009
Hydrazine-induced liver toxicity is enhanced by glutathione depletion but is not mediated by oxidative stress in HepG2 cellsEvelyn Olthof, Alma Tostmann, Wilbert H M Peters, et al.
Pageof 13